Indeed, sustained NKG2D stimulation is a typical hallmark in the tumor microenvironment: high expression of NKG2D ligands promotes receptor down-modulation from the cell surface, with a consequent impairment of NK cell functions both in humans and in mice [78]. The gene discussed is KLRK1; the disease is neoplasm.